The fourth vaccine to receive approval in parts of Europe, the Novavax shot, hasn't had any reports that I could find of myocarditis.

Disclosure : I hold no position in NVAX, short sell or options. I also don't hold Takeda Pharmaceuticals, at either their US listed shares or CFDs of their Tokyo listing.